Avara is a contract manufacturing organization committed to developing a collaborative relationship with clients to produce quality products.
Sterile Fill-Finish
We offer liquid and lyophilized fill-finish of sterile injectable products, including terminal sterilization and high containment capabilities for potent compounds.
Global Reach to 40+ Countries
Oral Solid Dose
Clinical and commercial-scale manufacturing of oral solid dose (OSD) drug product is a core capability of Avara, including potent compounds and targeted release formulations.
2 Billion Doses a Year
Packaging
Each of our sites provide integrated packaging for the dosage forms they manufacture, including primary and secondary packaging services, automated inspection, specialty packaging, and serialization to international requirements.
Integrated Packaging,
Automated Inspection
ABOUT AVARA
Avara is a contract manufacturing organization with established facilities proven through decades of large-scale commercial supply within the pharmaceutical industry. We build on inherent long-term site expertise with an established company commitment to attentiveness, flexibility, and fundamentally making it about you.
- Process Development
- Liquid & Lyophilized Steriles
- Oral Solid Dosage Forms
- Potent Compounds
- Analytical Support
- Integrated Packaging
FACILITIES
Aiken
South Carolina, USA
- Oral Solid Dose
- OTC portfolio legacy
- Multiple Rx-To-OTC Switches
- Specialty Packaging
- Former GSK facility
FACILITIES
Arecibo
Puerto Rico
- Oral Solid Dose
- Advanced Technologies
- DEA Controlled Drug II-V
- Highly Potent Products
- High-Speed Bottling
- Former Merck facility
FACILITIES
Liscate
Italy
- Sterile Injectables
- Pilot-Commercial Scale-Up
- €30m Invested Since 2009
- High Containment
- Former Pfizer facility
FACILITIES
Norman
Oklahoma, USA
- Oral Solid Dose
- Clinical — Commercial Scale
- Potent Products
- High-Resolution Inspection
- Avara’s Corporate Headquarters
- Former Astellas facility
Thought Leadership
October 2020
Avara Pharmaceutical Services: Achieving Successful OSD Rx-to- OTC Conversions
In The News
August 2020
How Avara is Innovating Through Pandemic and Beyond to Define the Future of Healthcare.
CONTACT AVARA
We want to hear from you, understand your objectives, and discuss how we can build the perfect relationship for your next project.